Skip to content
Sign in
Venture capitalBacked 1 network startup

AirTree Ventures

Sydney early-stage VC backing Australian and New Zealand founders from idea to global scale (Canva, Linktree, ProcurePro).

Sydney, Australia airtree.vc LinkedIn
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Seedto Series B and later
Network startups backed
1
Co-investors
4most often with Saniel Ventures

How they invest

Australian and New Zealand founders building global technology companies, idea to global scale. Portfolio (Canva, Linktree, Eucalyptus, Advanced Navigation, Qwilr, ProcurePro) mixes SaaS, consumer and deep tech, with repeat follow-on (three ProcurePro rounds).

Stage and ticket

Seed, Series A and Series B and later; tickets not disclosed in the record.

Geography

Australia, New Zealand, Oceania. Founders must be ANZ-based or ANZ-origin.

Thesis

Backs Australian and New Zealand founders from idea to global scale.

What makes them say yes

  • ANZ founder with a global category ambition
  • Strong product pull and capital efficiency
  • Potential for multi-round follow-on

Red flags

  • Non-ANZ founders
  • Local-only market ceiling

Sectors

Not published

Stages

  • Seed
  • Series A
  • Series B and later

Geographies

  • Australia
  • New Zealand
  • Oceania

How to approach

Warm intro via ProcurePro's founders (network peer, three AirTree rounds). Otherwise use AirTree's open founder channels with a concise global-scale narrative.

Portfolio

1 network startup · 5 other companies

Backs breakout ANZ category leaders and supports them through multiple rounds (ProcurePro seed, Series A and Series B). Construction-tech exposure through ProcurePro.

Gaps in the portfolio

  • No network ANZ climate or materials company
  • No network ANZ health company

Network startups

  • ProcureProSWC 2026 Top 10

    AI procurement control centre for general contractors, adopted by Bouygues, Multiplex and Mirvac, digitising the tender-to-subcontract cycle.

    Australia · AI & software

    • Series B (label varies by source: Series B / growth) · $11M · 1 May 2026Source
    • seed · 1 Oct 2021Source
    • Series ALeadSource

Other portfolio companies

From the investor's own sources. These companies are not on the network yet.

  • Advanced Navigation
  • Canva
  • Eucalyptus
  • Linktree
  • Qwilr

Network startups that fit

4 analysed

Nano-engineered activator letting ready-mix producers replace up to 50% of cement with low-carbon binders, cutting both cost and CO2.

New Zealand low-carbon concrete additive used commercially in Brunei: ANZ founder, global decarbonisation market, adjacent to AirTree's construction exposure via ProcurePro. Seed with US$3.5M raised fits the next round.

60%confidence

Evidence from the records

  • “Low-carbon concrete / cement additives”
  • “New Zealand”
  • “Backs Australian and New Zealand founders from idea to global scale.”
Intro path
ProcurePro (AirTree portfolio; network peer selling to large general contractors)
First step
Ask ProcurePro to introduce NEOCRETE and its contractor customers to AirTree.

Sydney medtech designing JUNO, a pocket-sized tankless oxygen concentrator for chronic respiratory patients, in clinical development with US partners.

Australian portable oxygen therapy with Texas Medical Center and NSW Health partners: an ANZ founder going global in medtech. Pre-seed and pre-approval, so regulatory risk is high.

40%confidence

Evidence from the records

  • “Portable oxygen therapy”
  • “partners Texas Medical Center, NSW Health SESLHD, UNSW”
First step
Pitch with a regulatory pathway and first clinical milestones.

Melbourne start-up developing an at-home urine test with machine learning to screen for endometriosis.

Australian endometriosis diagnostics with AI at the core: a large underserved women's health market. No published clinical study, so it is too early for most AirTree cheques.

25%confidence

Evidence from the records

  • “Women's health diagnostics (endometriosis)”
  • “Australia”
First step
Return after first clinical validation data.

University of Otago neuroscience spin-off led by Prof. John Reynolds, with Volpara co-founder Ralph Highnam bringing exit experience.

NZ University of Otago therapeutics spin-off: ANZ origin but preclinical and outside AirTree's visible tech portfolio.

15%confidence

Evidence from the records

  • “University therapeutics spin-off (presumed neuroscience)”
  • “New Zealand”
First step
Low priority; check AirTree interest in biotech first.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Saniel Ventures, Glitch Capital, and ISAI

Sources

  1. 1airtree.vc/

Profile compiled from public sources. Unknown fields are left empty rather than estimated.